123531-88-4

Upstream product

• 60638-81-5 5-chlorosulfonyl-2-hydroxy-benzoicacid methylester 
• 506-59-2 N,N-dimethylammonium chloride 
• 119-36-8 methyl salicylate 
• 124-40-3 dimethyl amine 

Downstream Products

• 1285516-69-9 methyl 5-[(dimethylamino)sulfonyl]-2-[(phenylmethyl)oxy]benzoate 
• 790702-57-7 5-(dimethylsulfamoyl)-N-(5-methyl-1,3-thiazol-2-yl)-2-(pyrrolidin-1-yl)benzamide 
• 1285514-01-3 4-(benzyloxy)-N₁,N₁-dimethyl-N₃-(pyridin-3-yl)isophthalamide 
• 1285516-70-2 2-(benzyloxy)-5-(N,N-dimethylsulfamoyl)benzoic acid 

Relevant academic research and scientific papers

INHIBITORS OF N-LINKED GLYCOSYLATION AND METHODS USING SAME

The present invention includes novel compounds and methods for preventing or treating diseases associated with N-linked glycosylation in a subject in need thereof. The methods comprise administering to the subject an effective amount of at least one compo

NOVEL COMPOUNDS

The present invention discloses novel compounds inhibiting LRRK2 kinase activity, the preparation processes thereof, the compositions containing them, as well as the use in treating diseases characterized by LRRK2 kinase activity, particularly Parkinson's disease and Alzheimer's disease.